nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—Sulfasalazine—ankylosing spondylitis	0.658	1	CrCtD
Sulfadiazine—Sulfaphenazole—Sulfasalazine—ankylosing spondylitis	0.125	0.52	CrCrCtD
Sulfadiazine—Sulfapyridine—Sulfasalazine—ankylosing spondylitis	0.115	0.48	CrCrCtD
Sulfadiazine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0155	0.182	CbGbCtD
Sulfadiazine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0124	0.146	CbGbCtD
Sulfadiazine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0116	0.136	CbGbCtD
Sulfadiazine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00943	0.11	CbGbCtD
Sulfadiazine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00809	0.0947	CbGbCtD
Sulfadiazine—CYP3A4—Betamethasone—ankylosing spondylitis	0.00809	0.0947	CbGbCtD
Sulfadiazine—CYP3A4—Prednisolone—ankylosing spondylitis	0.00798	0.0934	CbGbCtD
Sulfadiazine—CYP3A4—Prednisone—ankylosing spondylitis	0.00754	0.0882	CbGbCtD
Sulfadiazine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0047	0.0551	CbGbCtD
Sulfadiazine—Necrolysis epidermal—Methotrexate—ankylosing spondylitis	0.000586	0.0352	CcSEcCtD
Sulfadiazine—Lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.00054	0.0325	CcSEcCtD
Sulfadiazine—Reaction gastrointestinal—Methotrexate—ankylosing spondylitis	0.000398	0.024	CcSEcCtD
Sulfadiazine—Anuria—Methotrexate—ankylosing spondylitis	0.000381	0.0229	CcSEcCtD
Sulfadiazine—Skin necrosis—Methotrexate—ankylosing spondylitis	0.000381	0.0229	CcSEcCtD
Sulfadiazine—Systemic lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.000364	0.0219	CcSEcCtD
Sulfadiazine—Neuritis—Prednisolone—ankylosing spondylitis	0.000293	0.0176	CcSEcCtD
Sulfadiazine—Neuritis—Triamcinolone—ankylosing spondylitis	0.00027	0.0162	CcSEcCtD
Sulfadiazine—Neuritis—Methylprednisolone—ankylosing spondylitis	0.000269	0.0162	CcSEcCtD
Sulfadiazine—Neuritis—Betamethasone—ankylosing spondylitis	0.000245	0.0147	CcSEcCtD
Sulfadiazine—Neuritis—Dexamethasone—ankylosing spondylitis	0.000245	0.0147	CcSEcCtD
Sulfadiazine—Eruption—Methotrexate—ankylosing spondylitis	0.000216	0.013	CcSEcCtD
Sulfadiazine—Neuritis—Prednisone—ankylosing spondylitis	0.000213	0.0128	CcSEcCtD
Sulfadiazine—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.000192	0.0116	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.000192	0.0115	CcSEcCtD
Sulfadiazine—Burning sensation—Methotrexate—ankylosing spondylitis	0.000191	0.0115	CcSEcCtD
Sulfadiazine—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.000174	0.0105	CcSEcCtD
Sulfadiazine—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.000174	0.0105	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.000164	0.00988	CcSEcCtD
Sulfadiazine—Vascular purpura—Triamcinolone—ankylosing spondylitis	0.000163	0.00983	CcSEcCtD
Sulfadiazine—Skin exfoliation—Prednisone—ankylosing spondylitis	0.000152	0.00914	CcSEcCtD
Sulfadiazine—Purpura—Triamcinolone—ankylosing spondylitis	0.000152	0.00912	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.000151	0.00908	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.000151	0.00906	CcSEcCtD
Sulfadiazine—Skin discolouration—Methotrexate—ankylosing spondylitis	0.000147	0.00885	CcSEcCtD
Sulfadiazine—Oliguria—Methotrexate—ankylosing spondylitis	0.000144	0.00868	CcSEcCtD
Sulfadiazine—Sepsis—Prednisone—ankylosing spondylitis	0.000138	0.0083	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000137	0.00824	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000137	0.00824	CcSEcCtD
Sulfadiazine—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000135	0.0081	CcSEcCtD
Sulfadiazine—Vascular purpura—Prednisone—ankylosing spondylitis	0.000129	0.00777	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.000127	0.00764	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000125	0.00751	CcSEcCtD
Sulfadiazine—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000124	0.00745	CcSEcCtD
Sulfadiazine—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000124	0.00743	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.00012	0.00722	CcSEcCtD
Sulfadiazine—Purpura—Prednisone—ankylosing spondylitis	0.00012	0.00721	CcSEcCtD
Sulfadiazine—Sepsis—Methotrexate—ankylosing spondylitis	0.000115	0.00694	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00011	0.00664	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00011	0.00663	CcSEcCtD
Sulfadiazine—Polyuria—Methotrexate—ankylosing spondylitis	0.00011	0.00661	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000102	0.00615	CcSEcCtD
Sulfadiazine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.0001	0.00604	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.0001	0.00603	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.0001	0.00603	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	9.97e-05	0.006	CcSEcCtD
Sulfadiazine—Pancreatitis—Prednisone—ankylosing spondylitis	9.79e-05	0.00589	CcSEcCtD
Sulfadiazine—Hallucination—Betamethasone—ankylosing spondylitis	9.13e-05	0.00549	CcSEcCtD
Sulfadiazine—Hallucination—Dexamethasone—ankylosing spondylitis	9.13e-05	0.00549	CcSEcCtD
Sulfadiazine—Ataxia—Methotrexate—ankylosing spondylitis	9.08e-05	0.00546	CcSEcCtD
Sulfadiazine—Depression—Prednisone—ankylosing spondylitis	8.87e-05	0.00534	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	8.72e-05	0.00525	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	8.69e-05	0.00523	CcSEcCtD
Sulfadiazine—Vertigo—Prednisolone—ankylosing spondylitis	8.6e-05	0.00517	CcSEcCtD
Sulfadiazine—Convulsion—Prednisolone—ankylosing spondylitis	8.29e-05	0.00499	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—ankylosing spondylitis	8.18e-05	0.00492	CcSEcCtD
Sulfadiazine—Hallucination—Prednisone—ankylosing spondylitis	7.95e-05	0.00478	CcSEcCtD
Sulfadiazine—Vertigo—Triamcinolone—ankylosing spondylitis	7.91e-05	0.00476	CcSEcCtD
Sulfadiazine—Vertigo—Methylprednisolone—ankylosing spondylitis	7.89e-05	0.00475	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	7.81e-05	0.0047	CcSEcCtD
Sulfadiazine—Convulsion—Triamcinolone—ankylosing spondylitis	7.63e-05	0.00459	CcSEcCtD
Sulfadiazine—Convulsion—Methylprednisolone—ankylosing spondylitis	7.61e-05	0.00458	CcSEcCtD
Sulfadiazine—Arthralgia—Methylprednisolone—ankylosing spondylitis	7.48e-05	0.0045	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—ankylosing spondylitis	7.42e-05	0.00446	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	7.37e-05	0.00444	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—ankylosing spondylitis	7.25e-05	0.00436	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	7.18e-05	0.00432	CcSEcCtD
Sulfadiazine—Vertigo—Betamethasone—ankylosing spondylitis	7.17e-05	0.00432	CcSEcCtD
Sulfadiazine—Vertigo—Dexamethasone—ankylosing spondylitis	7.17e-05	0.00432	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	7.17e-05	0.00431	CcSEcCtD
Sulfadiazine—Insomnia—Prednisolone—ankylosing spondylitis	7.06e-05	0.00425	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—ankylosing spondylitis	6.94e-05	0.00417	CcSEcCtD
Sulfadiazine—Convulsion—Dexamethasone—ankylosing spondylitis	6.92e-05	0.00416	CcSEcCtD
Sulfadiazine—Convulsion—Betamethasone—ankylosing spondylitis	6.92e-05	0.00416	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—ankylosing spondylitis	6.68e-05	0.00402	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	6.54e-05	0.00394	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	6.53e-05	0.00393	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	6.52e-05	0.00392	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	6.52e-05	0.00392	CcSEcCtD
Sulfadiazine—Insomnia—Triamcinolone—ankylosing spondylitis	6.5e-05	0.00391	CcSEcCtD
Sulfadiazine—Insomnia—Methylprednisolone—ankylosing spondylitis	6.48e-05	0.0039	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	6.38e-05	0.00384	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	6.38e-05	0.00384	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—ankylosing spondylitis	6.31e-05	0.0038	CcSEcCtD
Sulfadiazine—Vertigo—Prednisone—ankylosing spondylitis	6.25e-05	0.00376	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—ankylosing spondylitis	6.23e-05	0.00374	CcSEcCtD
Sulfadiazine—Anorexia—Betamethasone—ankylosing spondylitis	6.21e-05	0.00374	CcSEcCtD
Sulfadiazine—Anorexia—Dexamethasone—ankylosing spondylitis	6.21e-05	0.00374	CcSEcCtD
Sulfadiazine—Urticaria—Prednisolone—ankylosing spondylitis	6.21e-05	0.00373	CcSEcCtD
Sulfadiazine—Convulsion—Prednisone—ankylosing spondylitis	6.03e-05	0.00362	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—ankylosing spondylitis	5.99e-05	0.0036	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	5.94e-05	0.00357	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	5.94e-05	0.00357	CcSEcCtD
Sulfadiazine—Arthralgia—Prednisone—ankylosing spondylitis	5.92e-05	0.00356	CcSEcCtD
Sulfadiazine—Insomnia—Dexamethasone—ankylosing spondylitis	5.89e-05	0.00355	CcSEcCtD
Sulfadiazine—Insomnia—Betamethasone—ankylosing spondylitis	5.89e-05	0.00355	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	5.86e-05	0.00353	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisolone—ankylosing spondylitis	5.75e-05	0.00346	CcSEcCtD
Sulfadiazine—Urticaria—Triamcinolone—ankylosing spondylitis	5.71e-05	0.00343	CcSEcCtD
Sulfadiazine—Urticaria—Methylprednisolone—ankylosing spondylitis	5.69e-05	0.00342	CcSEcCtD
Sulfadiazine—Body temperature increased—Triamcinolone—ankylosing spondylitis	5.68e-05	0.00342	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisone—ankylosing spondylitis	5.68e-05	0.00341	CcSEcCtD
Sulfadiazine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	5.67e-05	0.00341	CcSEcCtD
Sulfadiazine—Decreased appetite—Dexamethasone—ankylosing spondylitis	5.67e-05	0.00341	CcSEcCtD
Sulfadiazine—Decreased appetite—Betamethasone—ankylosing spondylitis	5.67e-05	0.00341	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	5.63e-05	0.00338	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	5.63e-05	0.00338	CcSEcCtD
Sulfadiazine—Anorexia—Prednisone—ankylosing spondylitis	5.41e-05	0.00325	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	5.33e-05	0.00321	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	5.33e-05	0.00321	CcSEcCtD
Sulfadiazine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	5.29e-05	0.00318	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	5.28e-05	0.00318	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—ankylosing spondylitis	5.22e-05	0.00314	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—ankylosing spondylitis	5.2e-05	0.00313	CcSEcCtD
Sulfadiazine—Urticaria—Dexamethasone—ankylosing spondylitis	5.18e-05	0.00311	CcSEcCtD
Sulfadiazine—Urticaria—Betamethasone—ankylosing spondylitis	5.18e-05	0.00311	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	5.17e-05	0.00311	CcSEcCtD
Sulfadiazine—Abdominal pain—Dexamethasone—ankylosing spondylitis	5.15e-05	0.0031	CcSEcCtD
Sulfadiazine—Body temperature increased—Dexamethasone—ankylosing spondylitis	5.15e-05	0.0031	CcSEcCtD
Sulfadiazine—Abdominal pain—Betamethasone—ankylosing spondylitis	5.15e-05	0.0031	CcSEcCtD
Sulfadiazine—Body temperature increased—Betamethasone—ankylosing spondylitis	5.15e-05	0.0031	CcSEcCtD
Sulfadiazine—Insomnia—Prednisone—ankylosing spondylitis	5.13e-05	0.00309	CcSEcCtD
Sulfadiazine—Pruritus—Triamcinolone—ankylosing spondylitis	5.08e-05	0.00306	CcSEcCtD
Sulfadiazine—Pruritus—Methylprednisolone—ankylosing spondylitis	5.07e-05	0.00305	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—ankylosing spondylitis	5.04e-05	0.00303	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—ankylosing spondylitis	4.95e-05	0.00298	CcSEcCtD
Sulfadiazine—Decreased appetite—Prednisone—ankylosing spondylitis	4.93e-05	0.00297	CcSEcCtD
Sulfadiazine—Rash—Prednisolone—ankylosing spondylitis	4.92e-05	0.00296	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisolone—ankylosing spondylitis	4.92e-05	0.00296	CcSEcCtD
Sulfadiazine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	4.9e-05	0.00295	CcSEcCtD
Sulfadiazine—Headache—Prednisolone—ankylosing spondylitis	4.89e-05	0.00294	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	4.74e-05	0.00285	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	4.64e-05	0.00279	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	4.64e-05	0.00279	CcSEcCtD
Sulfadiazine—Nausea—Prednisolone—ankylosing spondylitis	4.64e-05	0.00279	CcSEcCtD
Sulfadiazine—Pruritus—Betamethasone—ankylosing spondylitis	4.61e-05	0.00277	CcSEcCtD
Sulfadiazine—Pruritus—Dexamethasone—ankylosing spondylitis	4.61e-05	0.00277	CcSEcCtD
Sulfadiazine—Vomiting—Triamcinolone—ankylosing spondylitis	4.57e-05	0.00275	CcSEcCtD
Sulfadiazine—Vomiting—Methylprednisolone—ankylosing spondylitis	4.56e-05	0.00274	CcSEcCtD
Sulfadiazine—Rash—Triamcinolone—ankylosing spondylitis	4.53e-05	0.00272	CcSEcCtD
Sulfadiazine—Dermatitis—Triamcinolone—ankylosing spondylitis	4.52e-05	0.00272	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—ankylosing spondylitis	4.52e-05	0.00272	CcSEcCtD
Sulfadiazine—Rash—Methylprednisolone—ankylosing spondylitis	4.52e-05	0.00272	CcSEcCtD
Sulfadiazine—Dermatitis—Methylprednisolone—ankylosing spondylitis	4.51e-05	0.00272	CcSEcCtD
Sulfadiazine—Urticaria—Prednisone—ankylosing spondylitis	4.51e-05	0.00271	CcSEcCtD
Sulfadiazine—Headache—Triamcinolone—ankylosing spondylitis	4.5e-05	0.00271	CcSEcCtD
Sulfadiazine—Headache—Methylprednisolone—ankylosing spondylitis	4.49e-05	0.0027	CcSEcCtD
Sulfadiazine—Body temperature increased—Prednisone—ankylosing spondylitis	4.49e-05	0.0027	CcSEcCtD
Sulfadiazine—Abdominal pain—Prednisone—ankylosing spondylitis	4.49e-05	0.0027	CcSEcCtD
Sulfadiazine—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.46e-05	0.00268	CcSEcCtD
Sulfadiazine—Diarrhoea—Betamethasone—ankylosing spondylitis	4.46e-05	0.00268	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	4.32e-05	0.0026	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—ankylosing spondylitis	4.29e-05	0.00258	CcSEcCtD
Sulfadiazine—Nausea—Triamcinolone—ankylosing spondylitis	4.27e-05	0.00257	CcSEcCtD
Sulfadiazine—Nausea—Methylprednisolone—ankylosing spondylitis	4.26e-05	0.00256	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisone—ankylosing spondylitis	4.18e-05	0.00252	CcSEcCtD
Sulfadiazine—Vomiting—Dexamethasone—ankylosing spondylitis	4.14e-05	0.00249	CcSEcCtD
Sulfadiazine—Vomiting—Betamethasone—ankylosing spondylitis	4.14e-05	0.00249	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—ankylosing spondylitis	4.12e-05	0.00248	CcSEcCtD
Sulfadiazine—Rash—Betamethasone—ankylosing spondylitis	4.11e-05	0.00247	CcSEcCtD
Sulfadiazine—Rash—Dexamethasone—ankylosing spondylitis	4.11e-05	0.00247	CcSEcCtD
Sulfadiazine—Dermatitis—Betamethasone—ankylosing spondylitis	4.11e-05	0.00247	CcSEcCtD
Sulfadiazine—Dermatitis—Dexamethasone—ankylosing spondylitis	4.11e-05	0.00247	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.1e-05	0.00246	CcSEcCtD
Sulfadiazine—Headache—Dexamethasone—ankylosing spondylitis	4.08e-05	0.00246	CcSEcCtD
Sulfadiazine—Headache—Betamethasone—ankylosing spondylitis	4.08e-05	0.00246	CcSEcCtD
Sulfadiazine—Pruritus—Prednisone—ankylosing spondylitis	4.02e-05	0.00242	CcSEcCtD
Sulfadiazine—Diarrhoea—Prednisone—ankylosing spondylitis	3.88e-05	0.00234	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	3.88e-05	0.00233	CcSEcCtD
Sulfadiazine—Nausea—Dexamethasone—ankylosing spondylitis	3.87e-05	0.00233	CcSEcCtD
Sulfadiazine—Nausea—Betamethasone—ankylosing spondylitis	3.87e-05	0.00233	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—ankylosing spondylitis	3.77e-05	0.00227	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—ankylosing spondylitis	3.75e-05	0.00226	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—ankylosing spondylitis	3.75e-05	0.00226	CcSEcCtD
Sulfadiazine—Vomiting—Prednisone—ankylosing spondylitis	3.61e-05	0.00217	CcSEcCtD
Sulfadiazine—Rash—Prednisone—ankylosing spondylitis	3.58e-05	0.00215	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisone—ankylosing spondylitis	3.58e-05	0.00215	CcSEcCtD
Sulfadiazine—Headache—Prednisone—ankylosing spondylitis	3.56e-05	0.00214	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.49e-05	0.0021	CcSEcCtD
Sulfadiazine—Nausea—Prednisone—ankylosing spondylitis	3.37e-05	0.00203	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—ankylosing spondylitis	3.36e-05	0.00202	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—ankylosing spondylitis	3.25e-05	0.00195	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—ankylosing spondylitis	3.02e-05	0.00181	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—ankylosing spondylitis	2.99e-05	0.0018	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—ankylosing spondylitis	2.99e-05	0.0018	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—ankylosing spondylitis	2.97e-05	0.00179	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—ankylosing spondylitis	2.82e-05	0.00169	CcSEcCtD
